Relay Therapeutics Insider Trades
NASDAQ: RLAYHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 2:44 PM ET
Last 12 months
- Purchases
- 0 · $0
- Sales
- 34 · $128.33M
- Shares bought / sold
- 0 / 6.77M
- Net activity
- Net selling $128.3 million
Relay Therapeutics insider activity
Over the last 12 months, Relay Therapeutics insiders reported 43 transactions on SEC Form 4: 0 open-market purchases and 34 sales. Insiders bought $0 and sold $128.3 million worth of stock, for net insider selling of $128.3 million. The largest seller was SVF Pauling (Cayman) Ltd & SOFTBANK VISION FUND (AIV M2) L.P. & SB INVESTMENT ADVISERS (UK) LTD, with $116.4 million in reported sales.
The most recent filing shows Patel Sanjiv (President and CEO) selling 48,199 shares at $18.94 on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RLAY's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RLAY insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 8, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 17,717 | $335.56K | Form 4 |
| Sep 8, 2026 | Bergstrom Donald APresident, R&D | Sale | 8,530 | $161.81K | Form 4 |
| Sep 8, 2026 | Patel SanjivPresident and CEO | Sale | 48,199 | $912.89K | Form 4 |
| Aug 26, 2026 | Rahmer PeterSee remarks | Sale | 4,508 | $90.30K | Form 4 |
| Aug 25, 2026 | SVF Pauling (Cayman) Ltd & SOFTBANK VISION FUND (AIV M2) L.P. & SB INVESTMENT ADVISERS (UK) LTD10% Owner | Sale | 6,000,000 | $116.40M | Form 4 |
| Aug 17, 2026 | Patel SanjivPresident and CEO | Sale | 48,199 | $979.89K | Form 4 |
| Aug 14, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 17,717 | $349.73K | Form 4 |
| Jul 28, 2026 | Bergstrom Donald APresident, R&D | Sale | 2,237 | $41.63K | Form 4 |
| Jul 28, 2026 | Rahmer PeterSee remarks | Sale | 748 | $13.92K | Form 4 |
| Jul 28, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 1,459 | $27.15K | Form 4 |
| Jul 7, 2026 | Patel SanjivPresident and CEO | Sale | 48,199 | $943.74K | Form 4 |
| Jul 6, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 17,717 | $331.13K | Form 4 |
| Jul 6, 2026 | Bergstrom Donald APresident, R&D | Sale | 8,660 | $162.03K | Form 4 |
| Jun 30, 2026 | Rahmer PeterSee remarks | Award | 3,056 | $21.24K | Form 4 |
| Jun 30, 2026 | Rahmer PeterSee remarks | Sale | 50,000 | $954.50K | Form 4 |
| Jun 30, 2026 | Patel SanjivPresident and CEO | Award | 3,056 | $21.24K | Form 4 |
| Jun 22, 2026 | Bergstrom Donald APresident, R&D | Sale | 93,456 | $1.58M | Form 4 |
| Jun 22, 2026 | Bergstrom Donald APresident, R&D | Option exercise | 93,456 | $385.04K | Form 4 |
| Jun 22, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 51,560 | $874.97K | Form 4 |
| Jun 22, 2026 | Catinazzo ThomasChief Financial Officer | Option exercise | 51,560 | $229.44K | Form 4 |
| Jun 22, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 61,563 | $1.04M | Form 4 |
| Jun 22, 2026 | Catinazzo ThomasChief Financial Officer | Option exercise | 61,563 | $321.36K | Form 4 |
| Jun 22, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 56,323 | $955.80K | Form 4 |
| Jun 22, 2026 | Catinazzo ThomasChief Financial Officer | Option exercise | 56,323 | $283.87K | Form 4 |
| Jun 22, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 17,717 | $301.37K | Form 4 |
| May 14, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 17,717 | $227.84K | Form 4 |
| Apr 28, 2026 | Bergstrom Donald APresident, R&D | Sale | 1,490 | $22.04K | Form 4 |
| Apr 28, 2026 | Rahmer PeterSee remarks | Sale | 753 | $11.14K | Form 4 |
| Apr 28, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 972 | $14.38K | Form 4 |
| Apr 9, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 1,800 | $27.00K | Form 4 |
| Apr 9, 2026 | Catinazzo ThomasChief Financial Officer | Option exercise | 1,800 | $9.40K | Form 4 |
| Apr 7, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 17,717 | $230.50K | Form 4 |
| Mar 9, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 17,717 | $178.23K | Form 4 |
| Jan 28, 2026 | Rahmer PeterSee remarks | Sale | 1,354 | $11.44K | Form 4 |
| Jan 28, 2026 | Bergstrom Donald APresident, R&D | Sale | 2,686 | $22.70K | Form 4 |
| Jan 28, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 1,695 | $14.32K | Form 4 |
| Jan 27, 2026 | Rahmer PeterSee remarks | Sale | 11,684 | $89.03K | Form 4 |
| Jan 27, 2026 | Bergstrom Donald APresident, R&D | Sale | 18,895 | $143.98K | Form 4 |
| Jan 27, 2026 | Catinazzo ThomasChief Financial Officer | Sale | 13,820 | $105.31K | Form 4 |
| Jan 6, 2026 | Patel SanjivPresident and CEO | Sale | 43,168 | $337.57K | Form 4 |
| Dec 31, 2025 | Patel SanjivPresident and CEO | Award | 994 | $2.97K | Form 4 |
| Dec 31, 2025 | Rahmer PeterSee remarks | Award | 994 | $2.97K | Form 4 |
| Nov 3, 2025 | Patel SanjivPresident and CEO | Sale | 62,073 | $434.51K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4